Guidelines for applicants

Transcripción

Guidelines for applicants
ERASynBio 2nd joint call for transnational research projects:
Building Synthetic Biology capacity through innovative
transnational projects
GUIDELINES FOR APPLICANTS
DEADLINE FOR SUBMISSION: 17:00 CET on 3rd of July 2014
Online Access: http://www.erasynbio.eu/2nd-call
CONTENT
1 INTRODUCTION ......................................................................................................................... 1
2 SUBMISSION ............................................................................................................................. 2
3 APPLICATION ............................................................................................................................ 2
4 ELIGIBILITY ............................................................................................................................... 4
5 EVALUATION ............................................................................................................................ 5
6 FUNDING ................................................................................................................................. 5
7 MONITORING ........................................................................................................................... 5
8 CHECKLIST FOR APPLICANTS ...................................................................................................... 6
1 INTRODUCTION
These guidelines briefly explain how to apply for an ERASynBio grant. It is a one-step procedure for
the joint application.
For detailed guidance about the procedure, eligibility and evaluation criteria of this 2nd ERASynBio
joint call, applicants should refer to the corresponding Call Text provided on the ERASynBio website:
http://www.erasynbio.eu/2nd-call
All call procedures will be administered by the Call Office, under strict confidentiality. Please contact
the Call Office with any questions regarding the organisation or administration of this call.
Dr. Annette Kremser
Project Management Jülich, Division Biological Innovation and Economy (BIO)
Forschungszentrum Jülich GmbH, 52425 Jülich, Germany
phone: +49 2461 61-3213
fax: +49 2461 61-1790
email: [email protected]
1
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728
2 SUBMISSION
A single joint proposal document in English should be prepared by the partners and must be
submitted electronically by the coordinator of each project via the online submission tool at
http://www.erasynbio.eu/2nd-call. All fields requested by the electronic system are mandatory.
Original signed versions will not be required.
Proposals can only be submitted prior to 17:00 CET on 3rd of July 2014. Each project coordinator
should make sure to register the proposal early enough as a hard deadline is applied. After this
deadline, the website will neither accept modification nor submission of any proposal. The project
coordinator should also not underestimate the effort needed to collect the required information
from their project partners or fill in the online forms. ERASynBio therefore, strongly recommends
submitting proposals well before the deadlines.
General issues:
• A Coordinator should be identified for each collaborative research project, who is the
primary contact person for the consortium. In addition, a principal investigator (PI) should be
designated from each of the other collaborative institutions (named ‘partner’ in the Online
Form).
• Only the coordinator of a project consortium should register, edit and save the electronic
forms, upload the ’Project description’ and submit the proposal on behalf of the project
consortium. The other consortium partners should only enter their specific data.
• Applicants should take note of individual regulations mentioned in the National Annexes, and
should contact their National contact persons for any queries related to these Annexes.
• If consortium partners are requested to submit separate or different proposal documents
(see national annex of the call text), the consortium partner(s) concerned shall submit these
documents directly to the respective national / regional funding organization.
• After successful submission the main applicant will receive a confirmation of receipt. If your
application is deemed ineligible, you will subsequently receive feedback from the Call Office/
National contact persons.
• Incomplete proposals as well as applications submitted by mail, fax, CD-ROM or E-mail will
not be processed.
• The proposal is stored on a password-protected server. Connection to the server is SSLencoded and data safety and protection of confidence are warranted. The information given
in the proposal is binding and changes at a later stage during or after the evaluation (e.g.
composition of consortia) are subject to approval by the funding organisations involved.
• Please be aware that the project description should allow evaluators to assess properly all
evaluation criteria as laid down in the call text.
3 APPLICATION
Applicants must respect the format and length indicated for the proposal sections otherwise their
proposal will be rejected without further review.
A proposal consists of two parts: The online form, which contains the administrative information
such as the basic project and partner data and budget issues and the uploaded project description,
2
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728
which presents the project concept including the project objectives and work plan, the expected
results and their potential exploitation.
Online form:
• First a coordinator has to register.
• Only the coordinator is able to add partners to the proposal. Partners are able to edit their
own description.
• Overview: Please choose a meaningful title, acronym and the scientific field your proposal
relates to. The strategic element you choose should be related to one of the four themes of
the strategic vision (downloadable from the website).
• Keywords: Applicants should add keywords to enable effective reviewer selection and grant
classification. Below is a non-exhaustive list of potential keywords:
o Chassis (e.g Genome minimization, Genome engineering & modularization, Minimal
genome, Artificial cell & protocells, Synthetic organelles)
o System (e.g. Orthogonal systems, Synthetic circuits, Operon engineering)
o Device (e.g. Design of metabolic pathways, Synthetic regulatory devices, Scaffolding,
compartmentalization & Metabolic channelling)
o Part (e.g. Protein, DNA, RNA)
o Tools & Methods (e.g. In silico, DNA recombination)
o In vitro:
 Nanostructures (e.g Proteins, DNA, RNA)
 In vitro systems (e.g Proteins, DNA, RNA – scaffolds)
 Hybrid parts and systems
o In vivo: (e.g. Bacteria, Yeast, Plants, Mammalians)
• Coordinator / Partner Profile: this section contains all particulars of the applicants.
Coordinator and partners shall describe their project task(s) and their preliminary and
ongoing related work. A CV of each applicant (one page per person) is required. CVs
should include full contact details, current position, research interests and expertise.
Finally, the five most relevant publications should be added to the table.
• Budget:
An estimate of total project costs (in €) should be given per partner including the total
personnel, travel, consumables, equipment, subcontracting and other costs requested
plus overhead.
o Requested funding: The total costs are the sum of the direct plus indirect
(=overhead) costs. The reimbursement rate is the national funding rate applied
to your type of organisation and research. The requested funding is the
reimbursement rate divided by the total costs. For example:
Total cost
€500,000
o
Reimbursement rate
0.8 (80%)
Requested funding
€400,000
Own contribution is defined as estimate of the institute’s own investment in
the project and/or the investment of applicants who cannot be funded by
ERASynBio.
3
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728
o
o
All items should be briefly described. The number of full time equivalents
involved in the project should be listed.
Applicants using their own funding will need to demonstrate that this support
is available by providing a written confirmation on available funds.
Project description
The project description is the template containing the main part of the scientific proposal. When
writing the proposal, please follow the guidelines outlined for each item/ section in the template.
Please download the "Project Description" (word template) from the website, complete it, convert it
into pdf format and then upload the file to the submission website. Other file formats will not be
accepted by the system. If you have already uploaded a file before, it will be overwritten by any
subsequent file uploaded. Your file should not exceed 10 Mb in size. It may take some minutes to
complete the upload.
4 ELIGIBILITY
PLEASE NOTE
Prior to submitting the proposal, project partners are strongly advised to read
the ERASynBio and national eligibility criteria described on p 9-11 (6
ELIGIBILITY) and p 19-33 (ANNEX V: NATIONAL REGULATIONS OVERVIEW and
ANNEX VI: NATIONAL REGULATIONS DETAILS) of the call text.. For additional
clarification, applicants should contact their respective national funding
organisation contact persons. Only proposals meeting all eligibility criteria
(joint ERASynBio and national criteria) will be considered for evaluation and
there will be no opportunity to correct errors in the proposals after the
application deadline.
Consortium Agreement
All project participants will be required to sign a Consortium Agreement (CA) before the start of the
project, which must address (as a minimum), the following points:
•
expected start date and duration of the research project
•
organisation and management of the project
•
role and responsibilities of each partner resources and funding
•
confidentiality and publishing
•
Intellectual Property Rights
•
decision making within the consortium
•
handling of internal disputes
•
the liabilities of the research partners towards one another (including the handling of default
of contract).
Any issues regarding funding are a bilateral matter between each project partner and the relevant
funding organization and should be excluded from the consortium agreement.
4
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728
The CA, together with any other information required by national regulations, must be made
available on request to the national funding agencies. A CA template is available at
http://www.desca-2020.eu/.
5 EVALUATION
Proposals will be remotely reviewed based on the criteria that are published in the Call Text. The
coordinator will have the opportunity to comment on the remote reviews (rebuttal step). An Expert
Evaluation Panel will produce a ranking list of the proposals. This list will then be further considered
by the Call Group (comprising funding organisation representatives) taking into account budgetary
issues, leading to the final list of proposals recommended for funding. This list is forwarded to the
national funding organizations, which will make the final funding decisions regarding their national
applicants.
Conflict of interest:
In exceptional cases, applicants may ask the Call Office not to assign their applications to a certain
expert for evaluation in order to avoid individual conflicts of interest. The decision on potential
substitution of evaluators shall be taken by the funding organizations. Such a request must reach the
secretariat by the 3rd of July 2014 at the latest. The request will be treated confidentially.
It is also possible to recommend certain evaluators with highly specialized expertise for the proposed
research topic by the 3rd of July 2014 the latest.
Confidentiality
ERASynBio ensures complete confidentiality to applicants. The proposal will only be read by national
funding organisations and reviewers, and only be handled by the Call Office. All of these persons will
have signed a confidentiality agreement.
6 FUNDING
Project budgets must convincingly allow the achievement of the project objectives and should not
exceed national funding limits for each partner (for details, see Annex II and V “Eligibility of costs,
maximum funding per grant”). Applicants are strongly advised to consult their national contact
persons for details.
7 MONITORING
Each project consortium coordinator, on behalf of all participating partners, has to provide a
scientific progress report at midterm of the project and a comprehensive final report upon its
completion, which has to be sent to the call office. Additional monitoring can be performed
according to national requirements, e.g. necessary financial monitoring according to national rules.
Project coordinators have to present the project progress at status seminars per request by the call
office. An executive non-confidential summary that is part of the final reports will be published on
the ERASynBio homepage. Any publications resulting from the funded projects must acknowledge
the respective national funding organisations and the ERA-NET ERASynBio; one copy must be sent to
the Call Office.
5
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728
8 CHECKLIST FOR APPLICANTS
Application scheme
Single step procedure, no pre-proposals
Access to submission
http://www.erasynbio.eu/2nd-call
Deadline for
submission
3rd of July 2014
Eligibility criteria
fulfilled?
•
•
•
•
•
submission in English
Consortium – “who”: public and private organisations including
universities, other higher education institutions, research
organisations and commercial companies (depending on national
regulations)
Consortium – “how many”: partners from at least three different
partner countries (outlined in para. 1), and no more than seven
partners in total.
Duration: three years
Specific national criteria
Strategic element chosen
Evaluation criteria
addressed?
•
•
•
Scientific and technological quality
Impact
Implementation
Rebuttal phase?
Consortium
Agreement?
Compliance with
fundamental ethical
principles?
Yes, see section 7 “Evaluation”
Yes, prior to project start
•
Check EGE No. 25 (http://ec.europa.eu/bepa/european-groupethics/docs/opinion25_en.pdf) or for US partners
(http://www.nsf.gov/pubs/policydocs/pappguide/nsf14001/gpg_2.jsp).
6
ERASynBio is funded by the European Commission’s Framework Programme. Contract No. 291728

Documentos relacionados